These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 19396424)

  • 61. Multicentre randomized controlled trial with sensor-augmented pump vs multiple daily injections in hospitalized patients with type 2 diabetes in China: Time to reach target glucose.
    Gu W; Liu Y; Chen Y; Deng W; Ran X; Chen L; Zhu D; Yang J; Shin J; Lee SW; Cordero TL; Mu Y
    Diabetes Metab; 2017 Sep; 43(4):359-363. PubMed ID: 28236571
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Routine use of continuous glucose monitoring in 10 501 people with diabetes mellitus.
    Battelino T; Liabat S; Veeze HJ; Castañeda J; Arrieta A; Cohen O
    Diabet Med; 2015 Dec; 32(12):1568-74. PubMed ID: 26042926
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
    JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Assessment of patient-led or physician-driven continuous glucose monitoring in patients with poorly controlled type 1 diabetes using basal-bolus insulin regimens: a 1-year multicenter study.
    Riveline JP; Schaepelynck P; Chaillous L; Renard E; Sola-Gazagnes A; Penfornis A; Tubiana-Rufi N; Sulmont V; Catargi B; Lukas C; Radermecker RP; Thivolet C; Moreau F; Benhamou PY; Guerci B; Leguerrier AM; Millot L; Sachon C; Charpentier G; Hanaire H;
    Diabetes Care; 2012 May; 35(5):965-71. PubMed ID: 22456864
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A pilot study of factors associated with glycaemic control in adults with Type 1 diabetes mellitus on insulin pump therapy.
    Wen W; Frampton R; Wright K; Fattore S; Shadbolt B; Perampalam S
    Diabet Med; 2016 Feb; 33(2):231-4. PubMed ID: 26484625
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy.
    Launer LJ; Miller ME; Williamson JD; Lazar RM; Gerstein HC; Murray AM; Sullivan M; Horowitz KR; Ding J; Marcovina S; Lovato LC; Lovato J; Margolis KL; O'Connor P; Lipkin EW; Hirsch J; Coker L; Maldjian J; Sunshine JL; Truwit C; Davatzikos C; Bryan RN;
    Lancet Neurol; 2011 Nov; 10(11):969-77. PubMed ID: 21958949
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Association of Achieving Time in Range Clinical Targets With Treatment Modality Among Youths With Type 1 Diabetes.
    Dovc K; Lanzinger S; Cardona-Hernandez R; Tauschmann M; Marigliano M; Cherubini V; Preikša R; Schierloh U; Clapin H; AlJaser F; Pelicand J; Shukla R; Biester T
    JAMA Netw Open; 2023 Feb; 6(2):e230077. PubMed ID: 36808243
    [TBL] [Abstract][Full Text] [Related]  

  • 68. CGM-measured glucose values have a strong correlation with C-peptide, HbA1c and IDAAC, but do poorly in predicting C-peptide levels in the two years following onset of diabetes.
    Buckingham B; Cheng P; Beck RW; Kollman C; Ruedy KJ; Weinzimer SA; Slover R; Bremer AA; Fuqua J; Tamborlane W;
    Diabetologia; 2015 Jun; 58(6):1167-74. PubMed ID: 25773405
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Overcoming clinical inertia in insulin initiation in primary care for patients with type 2 diabetes: 24-month follow-up of the Stepping Up cluster randomised controlled trial.
    Manski-Nankervis JA; Furler J; O'Neal D; Ginnivan L; Thuraisingam S; Blackberry I
    Prim Care Diabetes; 2017 Oct; 11(5):474-481. PubMed ID: 28705697
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Glucose profiles of older adults with type 1 diabetes using sensor-augmented pump therapy in Australia: pre-randomisation results from the ORACL study.
    Trawley S; Ward GM; Vogrin S; Colman PG; Fourlanos S; Grills CA; Lee MH; MacIsaac RJ; Alipoor AM; O'Neal DN; O'Regan NA; Sundararajan V; McAuley SA
    Lancet Healthy Longev; 2022 Dec; 3(12):e839-e848. PubMed ID: 36410370
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Determinants of glycaemic outcome in the current practice of care for young people up to 21 years old with type 1 diabetes under real-life conditions.
    Kordonouri O; Lange K; Biester T; Datz N; Kapitzke K; von dem Berge T; Weiskorn J; Danne T
    Diabet Med; 2020 May; 37(5):797-804. PubMed ID: 31498923
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A randomised controlled trial to assess the antithrombotic effects of aspirin in type 1 diabetes: role of dosing and glycaemic control.
    Parker WAE; Sagar R; Kurdee Z; Hawkins F; Naseem KM; Grant PJ; Storey RF; Ajjan RA
    Cardiovasc Diabetol; 2021 Dec; 20(1):238. PubMed ID: 34920734
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Glycaemic control in individuals with type 1 diabetes using an open source artificial pancreas system (OpenAPS).
    Melmer A; Züger T; Lewis DM; Leibrand S; Stettler C; Laimer M
    Diabetes Obes Metab; 2019 Oct; 21(10):2333-2337. PubMed ID: 31183929
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Route to improving Type 1 diabetes mellitus glycaemic outcomes: real-world evidence taken from the National Diabetes Audit.
    Heald AH; Livingston M; Fryer A; Moreno GYC; Malipatil N; Gadsby R; Ollier W; Lunt M; Stedman M; Young RJ
    Diabet Med; 2018 Jan; 35(1):63-71. PubMed ID: 29120503
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Relative Effectiveness of Pumps Over MDI and Structured Education (REPOSE): study protocol for a cluster randomised controlled trial.
    White D; Waugh N; Elliott J; Lawton J; Barnard K; Campbell MJ; Dixon S; Heller S;
    BMJ Open; 2014 Sep; 4(9):e006204. PubMed ID: 25186159
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial.
    O'Kane MJ; Bunting B; Copeland M; Coates VE;
    BMJ; 2008 May; 336(7654):1174-7. PubMed ID: 18420662
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Insulin pump therapy: impact on the lives of children/young people with diabetes mellitus and their parents.
    Alsaleh FM; Smith FJ; Thompson R; Al-Saleh MA; Taylor KM
    Int J Clin Pharm; 2014 Oct; 36(5):1023-30. PubMed ID: 25108411
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Is glycaemia or insulin dose the stronger risk factor for coronary artery disease in type 1 diabetes?
    Conway B; Costacou T; Orchard T
    Diab Vasc Dis Res; 2009 Oct; 6(4):223-30. PubMed ID: 20368215
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of Optimization of Glycaemic Control on Mannan-Binding Lectin in Type 1 Diabetes.
    Dørflinger GH; Holt CB; Thiel S; Østergaard JA; Hansen TK
    J Diabetes Res; 2017; 2017():1249729. PubMed ID: 29318157
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Open-Source Automated Insulin Delivery in Type 1 Diabetes.
    Burnside MJ; Lewis DM; Crocket HR; Meier RA; Williman JA; Sanders OJ; Jefferies CA; Faherty AM; Paul RG; Lever CS; Price SKJ; Frewen CM; Jones SD; Gunn TC; Lampey C; Wheeler BJ; de Bock MI
    N Engl J Med; 2022 Sep; 387(10):869-881. PubMed ID: 36069869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.